Top Healthcare Stock Holdings in Sterne Agee’s Latest 13F

Following is information regarding Sterne Agee’s top holdings in the Healthcare sector for the quarter ending September 30th, 2011:

  • Johnson & Johnson (NYSE:JNJ): On 6/30/11 Sterne Agee Group, Inc. reported holding 19,035 shares with a market value of $1,266,208. This comprised 0.61% of the total portfolio. On 9/30/11, Sterne Agee Group held 30,139 shares with a market value of $1,919,553. This comprised 1.30% of the total portfolio. The net change in shares for this position over the two quarters is 11,104. About the company: Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
  • Siga Technologies, Inc. (NASDAQ:SIGA): On 6/30/11 Sterne Agee Group, Inc. reported holding 475,550 shares with a market value of $4,631,857. This comprised 2.23% of the total portfolio. On 9/30/11, Sterne Agee Group held 427,600 shares with a market value of $1,398,252. This comprised 0.95% of the total portfolio. The net change in shares for this position over the two quarters is -47,950. About the company: SIGA Technologies, Inc. explores, develops, and markets products for use in defense against biological warfare agents. The Company’s also offers products such as novel anti-infectives or the prevention and treatment of serious infectious diseases.
  • Atrion Corp. (NASDAQ:ATRI): On 6/30/11 Sterne Agee Group, Inc. reported holding 3,750 shares with a market value of $741,750. This comprised 0.36% of the total portfolio. On 9/30/11, Sterne Agee Group held 3,750 shares with a market value of $777,712. This comprised 0.53% of the total portfolio. The net change in shares for this position over the two quarters is 0,000. About the company: Atrion Corporation, through its subsidiaries, designs, develops, manufactures, markets, sells, and distributes medical products and components. The Company’s products are used in ophthalmic, diagnostic, and cardiovascular procedures. Atrion’s products are sold primarily to health care companies which market and distribute its products in conjunction with their name-brand products.
  • Brisol-Myers Squibb Company (NYSE:BMY): On 6/30/11 Sterne Agee Group, Inc. reported holding 25,782 shares with a market value of $746,647. This comprised 0.36% of the total portfolio. On 9/30/11, Sterne Agee Group held 24,720 shares with a market value of $775,714. This comprised 0.53% of the total portfolio. The net change in shares for this position over the two quarters is -1,062. About the company: Bristol-Myers Squibb Company is a global biopharmaceutical company that discovers, develops, manufactures and sells pharmaceutical and nutritional products. The Company’s products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders.
  • Pfizer, Inc. (NYSE:PFE): On 6/30/11 Sterne Agee Group, Inc. reported holding 50,375 shares with a market value of $1,037,725. This comprised 0.50% of the total portfolio. On 9/30/11, Sterne Agee Group held 40,010 shares with a market value of $707,377. This comprised 0.48% of the total portfolio. The net change in shares for this position over the two quarters is -10,365. About the company: Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
  • Novo Nordisk a/s (NYSE:NVO): On 6/30/11 Sterne Agee Group, Inc. reported holding 5,322 shares with a market value of $666,740. This comprised 0.32% of the total portfolio. On 9/30/11, Sterne Agee Group held 4,762 shares with a market value of $473,914. This comprised 0.32% of the total portfolio. The net change in shares for this position over the two quarters is -0,560. About the company: Novo Nordisk A/S develops, produces, and markets pharmaceutical products. The Company focuses on diabetes care and offers insulin delivery systems and other diabetes products. Novo Nordisk also works in areas such as haemostatis management, growth disorders, and hormone replacement therapy. The Company offers educational and training materials. Novo Nordisk markets worldwide.
  • Abbott Laboratories (NYSE:ABT): On 6/30/11 Sterne Agee Group, Inc. reported holding 8,690 shares with a market value of $457,268. This comprised 0.22% of the total portfolio. On 9/30/11, Sterne Agee Group held 9,131 shares with a market value of $466,959. This comprised 0.32% of the total portfolio. The net change in shares for this position over the two quarters is 0,441. About the company: Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company’s products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors.

(Note: Data regarding Sterne Agee’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

Check out our analysis of Jim Cramer’s latest stock calls

More from The Cheat Sheet